Champions Oncology
Open
$6.48
Prev. Close
$6.48
High
$6.51
Low
$6.30
Market Snapshot
$90.26M
-39.6
-0.05
$53.57M
213
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Hackensack, New Jersey and currently employs 213 full-time employees. The firm is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions (TOS). This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The company also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Hackensack, New Jersey and currently employs 213 full-time employees. The firm is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions (TOS). This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The company also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Recently from Cashu
Champions Oncology: Pioneering Personalized Cancer Treatment Through Innovative Biotech Solutions
Champions Oncology and the Imperative of Biotech Innovation Champions Oncology focuses on advancing personalized cancer treatment options through cutting-edge technology and innovative approaches to d…
Champions Oncology Leads in Precision Medicine with Innovative Cancer Treatment Solutions
### Champions Oncology: Harnessing Innovations in Precision Medicine Champions Oncology is currently at the forefront of the rapidly evolving landscape of oncology, focusing on the development of adva…
Champions Oncology: Pioneering Personalized Cancer Care Amid Market Volatility
Champions Oncology: Advancing Personalized Cancer Treatment in a Volatile Market Champions Oncology is at the forefront of personalized medicine, specifically in the oncology sector, where it focuses…
Champions Oncology: Innovating Personalized Cancer Treatment in a Volatile Market
Champions Oncology's Role in the Evolving Landscape of Cancer Treatment Champions Oncology, a leader in personalized medicine and oncology, continues to innovate within the realm of cancer treatment,…